Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients
暂无分享，去创建一个
B. Pégourié | C. Sebban | P. Moreau | H. Avet-Loiseau | M. Macro | X. Leleu | G. Marit | J. Corre | T. Facon | F. Guilhot | M. Attal | B. Royer | L. Garderet | M. Roussel | L. Karlin | A. Stoppa | P. Lenain | F. Orsini-Piocelle | S. Bréchignac | M. Wetterwald | C. Hulin | D. Caillot | T. Lamy | L. Voillat | M. Chrétien | L. Legros | B. Hébraud | M. Dib | X. Delbrel | V. Cancès-Lauwers